VRTX

Transfer...
Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Slow Growth
# of Employee: 1,950 / Fiscal Year End: 2016-12-31 / Stock Type: Mid Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | ALXN | INCY | BMRN | VVUS |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-06-25Quarter138,421k17,300k0.0-159,382k-159,382k233,808,k87.50%-115.10%-115.10%
2014-09-25Quarter178,987k14,184k0.0-169,996k-170,060k236,137,k92.10%-95.00%-95.00%
2014-12-25Quarter144,556k14,027k0.0-180,637k-176,656k238,607,k90.30%-125.00%-122.20%
2015-03-25Quarter138,509k12,307k0.0-198,704k-198,606k239,493,k91.10%-143.50%-143.40%
2015-06-25Quarter166,076k16,860k0.0-220,992k-188,848k240,757,k89.80%-133.10%-113.70%
2015-09-25Quarter309,816k31,960k0.0-93,816k-95,149k241,969,k89.70%-30.30%-30.70%
2015-12-25Quarter417,935k63,385k0.0-74,669k-73,731k243,001,k84.80%-17.90%-17.60%
2016-03-25Quarter398,080k50,649k0.0-36,102k-41,631k243,831,k87.30%-9.10%-10.50%
2016-06-25Quarter431,608k45,252k0.0-36,151k-64,525k244,482,k89.50%-8.40%-14.90%
2016-09-25Quarter413,783k54,077k0.0-39,537k-38,841k244,920,k86.90%-9.60%-9.40%
2016-12-25Quarter458,706k60,482k20,439k27,759k32,945k245,153,k86.80%6.10%7.20%
2017-03-25Quarter714,718k46,988k16,765k249,548k247,756k248,700,k93.40%34.90%34.70%
2017-06-25Quarter544,135k71,205k14,664k31,169k17,996k251,635,k86.90%5.70%3.30%
2017-09-25Quarter578,165k72,874k13,574k-291,267k-102,952k250,268,k87.40%-50.40%-17.80%
2017-12-25Quarter651,634k84,052k12,547k102,185k100,684k256,615,k87.10%15.70%15.50%
2018-03-25Quarter640,799k71,613k11,097k227,301k210,263k258,526,k88.80%35.50%32.80%
2018-06-25Quarter752,157k104,382k10,106k206,250k207,360k258,584,k86.10%27.40%27.60%
2018-09-25Quarter784,535k111,255k8,143k128,456k128,746k259,788,k85.80%16.40%16.40%
2018-12-25Quarter870,106k122,289k4,773k1,525,096k1,550,527k259,824,k85.90%175.30%178.20%
2019-03-25Quarter858,435k95,092k14,868k268,631k268,631k260,175,k88.90%31.30%31.30%
2019-06-25Quarter941,293k135,740k14,837k267,427k267,427k259,822,k85.60%28.40%28.40%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-06-25Quarter19.98%-2.54%0.00%38.66%18.49%2.97%2.63%15.64%-1.22%
2015-09-25Quarter73.09%125.32%0.00%-44.81%-44.05%2.47%-2.61%-68.11%-67.68%
2015-12-25Quarter189.12%351.88%0.00%-58.66%-58.26%1.84%-6.09%-85.68%-85.60%
2016-03-25Quarter187.40%311.55%0.00%-81.83%-79.04%1.81%-4.17%-93.66%-92.68%
2016-06-25Quarter159.89%168.40%0.00%-83.64%-65.83%1.55%-0.33%-93.69%-86.90%
2016-09-25Quarter33.56%69.20%0.00%-57.86%-59.18%1.22%-3.12%-68.32%-69.38%
2016-12-25Quarter9.76%-4.58%0.00%-137.18%-144.68%0.89%2.36%-134.08%-140.91%
2017-03-25Quarter79.54%-7.23%0.00%-791.23%-695.12%2.00%6.99%-483.52%-430.48%
2017-06-25Quarter26.07%57.35%0.00%-186.22%-127.89%2.93%-2.91%-167.86%-122.15%
2017-09-25Quarter39.73%34.76%0.00%636.69%165.06%2.18%0.58%425.00%89.36%
2017-12-25Quarter42.06%38.97%-38.61%268.11%205.61%4.68%0.35%157.38%115.28%
2018-03-25Quarter-10.34%52.41%-33.81%-8.91%-15.13%3.95%-4.93%1.72%-5.48%
2018-06-25Quarter38.23%46.59%-31.08%561.72%1,052.26%2.76%-0.92%380.70%736.36%
2018-09-25Quarter35.69%52.67%-40.01%-144.10%-225.05%3.80%-1.83%-132.54%-192.13%
2018-12-25Quarter33.53%45.49%-61.96%1,392.49%1,439.99%1.25%-1.38%1,016.56%1,049.68%
2019-03-25Quarter33.96%32.79%33.98%18.18%27.76%0.64%0.11%-11.83%-4.57%
2019-06-25Quarter25.15%30.04%46.81%29.66%28.97%0.48%-0.58%3.65%2.90%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter1,156,582k2,896,787k1,740,205k1,831,540k792,537k947,668k.665.433
2017-03-25Quarter1,500,008k2,946,703k1,446,695k1,871,814k489,796k956,899k1.037.262
2017-06-25Quarter1,671,273k3,285,594k1,614,321k2,180,572k625,406k988,915k1.035.287
2017-09-25Quarter1,791,077k3,198,325k1,407,248k2,327,974k710,739k696,509k1.273.305
2017-12-25Quarter2,028,579k3,546,014k1,517,435k2,648,963k807,260k710,175k1.337.305
2018-03-25Quarter2,401,056k3,952,974k1,551,918k3,041,116k827,312k724,606k1.547.272
2018-06-25Quarter2,686,228k4,335,386k1,649,158k3,407,423k927,300k721,858k1.629.272
2018-09-25Quarter2,906,116k4,620,840k1,714,724k3,686,611k992,508k722,216k1.695.269
2018-12-25Quarter4,435,203k6,245,898k1,810,695k3,843,109k1,120,292k690,403k2.449.292
2019-03-25Quarter4,723,313k6,543,114k1,819,801k4,183,039k1,106,468k713,333k2.596.265

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter75.39%22.41%-12.80%44.63%1.86%-25.06%101.05%-29.56%
2018-03-25Quarter60.07%34.15%7.27%62.47%68.91%-24.28%49.18%3.82%
2018-06-25Quarter60.73%31.95%2.16%56.26%48.27%-27.01%57.39%-5.23%
2018-09-25Quarter62.26%44.48%21.85%58.36%39.64%3.69%33.15%-11.80%
2018-12-25Quarter118.64%76.14%19.33%45.08%38.78%-2.78%83.17%-4.26%
2019-03-25Quarter96.72%65.52%17.26%37.55%33.74%-1.56%67.81%-2.57%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note